MedWatch

Action Pharma-CEO reuses sales model for daughter company

A vaccine company is to be sold by the same model as Action Pharma, explains Ingelise Saunders, who is CEO in both companies. If it fails, the project will have to be shelved.

Foto: Brian Hoskins / Stock.Xchng

If at first you do succeed, try again.

Following that mantra, Ingelise Saunders, who as acting CEO has just sold Action Pharma’s greatest asset to Abbott, will use the same model for the company TD Vaccines, which she is also the CEO of. The company currently has a vaccine for travelers’ diarrhea in phase II studies.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier